Advances in strategies to improve the immunotherapeutic efficacy of chimeric antigen receptor-T cell therapy for lymphoma
Chimeric antigen receptor-T (CAR-T) cell therapy is a precise immunotherapy for lymphoma. However, its long-term efficacy faces many challenges related to tumor cell heterogeneity, interference from immunosuppressive microenvironments, CAR-T cell exhaustion, and unmanageable adverse events. Diverse...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
China Anti-Cancer Association
2025-04-01
|
| Серии: | Cancer Biology & Medicine |
| Предметы: | |
| Online-ссылка: | https://www.cancerbiomed.org/content/22/4/301 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|